Introduction
The communicable disease tuberculosis (TB) is caused by the oldest human pathogen Mycobacterium tuberculosis (MTB). In the year 2013 nearly 1.5 million people died and 9.0 million new TB cases were reported [1] . MTB can survive in the host organism against the change in environmental conditions due to complex gene expression, which is controlled by specific Sigma factors [2, 3] . The Sigma factors, a regulatory family of proteins, play a key role in the immunopathology of MTB [4, 5] . The MTB encodes 13 Sigma factors, among which Sigma factor F (SigF) protein regulates the SigB and SigC factor protein expression, which are important in virulence [6] [7] [8] . The SigF is involved in direct and indirect regulation of many genes, which are essential for cell wall protein synthesis and survival of MTB in the host system [9, 10] . Geiman et al. reported that 187 genes in stationary phase and 277 genes in late stationary phase show less expression in the SigFdeficient MTB [11] . The Usfx, an anti-Sigma factor, negatively regulates the activity of SigF, in response to a variety of http://dx.doi.org/10.1016/j.ijmyco.2015.05.013 2212-5531/Ó 2015 Asian African Society for Mycobacteriology. Production and hosting by Elsevier Ltd. All rights reserved. physiological stress conditions [12, 13] . In the present work the in silico screening has been taken up to identify small molecules, which can act as antagonists for the SigF protein.
Methodology
The SigF protein binds to its cognate anti-SigF (Usfx) in its regulatory circuit; in the absence of Usfx, SigF initiates transcription initiation and gene expression, which leads to protein synthesis and in turn helps in the survival of MTB. Finding inhibitors for the SigF protein at the Usfx binding site will arrest the survival of MTB. In the present work in silico screening is taken up to identify competitive inhibitors for Usfx.
Virtual screening
The structure of SigF was considered from an earlier work [13] . The SigF structure was energy minimized using the protein preparation wizard in Maestro 9.0.111 (Maestro v 9.0.111 Schrodinger LLC, New York, NY) applying OPLS 2001 (optimized potential for liquid simulations 2001) force field with default parameters [14] . The Virtual screening work flow of Schrodinger involves three consecutive steps: (a) receptor grid generation; (b) ligand preparation; and (c) Glide ligand docking [15] . The grid was generated using the Gridgen module of Schrodinger Suite at the active site amino acid residues [13, 16] . The Sigma lifechem small molecule database was considered and retrieved in Sdf file format. The ligands were subjected to ligand preparation using the Ligprep 2.5 module of Schrodinger Suit [17] and during the process, tautomeric states and ionization states were generated using the epic module. The work flow utilizes the Glide module for Ligand and Receptor docking. Glide filters the molecules using HTVS (high throughput virtual screening), SP (standard precision) and XP (extra precision) modes [16] . The OPLS 2001 force field [14, 18] parameters were applied while performing docking calculations. The molecules with the best Glide score and Glide energy were visually inspected and considered for further analysis. The SASA (solvent accessible surface area) for the receptor and ligand complexes were calculated with the default parameters. The receptor-ligand complexes were analyzed using Accelrys Discovery Studio Visualizer (Accelrys Software Inc., 2007 Accelrys Discovery Studio Visualiser v 2.5.5. Accelrys Software Inc., San Diego).
ADME properties
The Absorption Distribution Metabolism and Elimination (ADME) properties were calculated using the QikProp [18] module of Schrodinger suite (QikProp, version 3.0, Schrodinger, LLC, New York, NY, 2010) for assessing the druggability and to filter the ligand molecules at an early stage of identifying the new antagonists.
Results and discussion

Virtual screening
The virtual screening studies are carried out with 12,000 small ligand molecules from the Sigma lifechem database. In the process, the grid box is generated with 75 · 75 · 75 Å 3 around the active site amino acids which were considered from an earlier study [13] . In the ligand preparation process using the epic program, 5 stereo isomers from 32 structures 0   20   40   60   80   100   120   140   160   1  10  19  28  37  46  55  64  73  82  91  100  109  118  127  136  145  154  163  172  181  190  199  208  217  226  235  244  253 SigF BD SigF-M3 ligand molecules from the HTVS screening process are considered for SP docking. The 679 ligand molecules are docked and the top 10% of SP docked molecules are utilized for XP docking mode. Finally, 68 docked complexes are generated in the XP flexible docking mode. The docked complexes are analyzed, visually inspected and the data of a sample of 6 molecules (M1 to M6) with the corresponding docking properties generated namely docking score, docking energy, docking interactions and ADME properties, are presented in Tables 1  and 2 . The hydrogen bond interactions and p cation interactions are depicted in Fig. 1 . The virtual screening analysis reveals that the amino acid residues ILE54, ARG57, GLU59, ARG104, ASP174 and ARG224 are involved in the hydrogen bond formation and p cation interactions with the M1 to M6 ligand molecules. The amide group oxygen in M6 molecule and the amide group oxygen in M1 to M5 molecules bound in the docked complex through hydrogen bonds with the amine hydrogen of ARG104 in SigF protein. 
analysis reveals the common presence of piperazine-l-yl acetic acid moiety and an amide group in all the ligands and is capable of binding effectively with ARG104 and ARG224 of the SigF protein. The SASA calculations are carried out for the SigF protein and the SigF-Ligand docked complexes and are represented in Fig. 2 . The SASA values of the SigF protein for the amino acid residues which are involved in bond formation (ILE54, ARG57, GLU59, ARG104, ASP174 and ARG224) and spatially nearby residues in the binding site decreased after docking when compared with that before docking. The decrease in SASA values confirms that these amino acid residues are involved in the bond formation with the ligand molecules.
ADME properties
The ADME properties for the new ligands identified namely M1 to M6 are calculated and tabulated in Table 2 . These molecules have properties within the limits projected as per the Lipinski rules of 5 and Jorgensen's rules of 3, with medium human oral absorption, which signifies that the ligand molecules have acceptable ADME properties.
Conclusion
The virtual screening studies performed using Sigma lifechem database against active site residues of SigF reveal ILE54, ARG57, GLU59, ARG104, ASP174 and ARG224 amino acid residues to be important for binding in the SigF protein. A sample of six ligands is presented in the present communication; several novel scaffolds are identified in the virtual screening studies. The piperazine-l-yl acetic acid moiety and an amide group in the ligands commonly exist and forms hydrogen bonds with ARG104 and ARG224 of the SigF protein. The ligand molecules show admissible ADME properties and are identified as novel antagonists for the SigF protein. Further work is in progress in the direction of identifying novel potent inhibitors for the SigF protein, which is important for virulence.
